AliveCor Launches KardiaComplete to Help Reduce the Rising Health and Economic Costs of Heart Disease

AliveCor today announced the launch of KardiaComplete, a comprehensive heart health enterprise solution designed to drive improved health outcomes and reduce the cost of cardiac care.

The service will be available to people diagnosed with hypertension and arrhythmias, like atrial fibrillation, through their self-insured employers, health insurance plans and health systems.

KardiaComplete also addresses the urgent need to democratize heart care as the United States faces a significant cardiologist shortage.1 By leveraging data from best-in-class cardiac monitoring solutions – AliveCor’s KardiaMobile 6L, the #1 doctor-recommended personal ECG, and Omron’s Evolv, the #1 doctor and pharmacist-recommended blood pressure cuff – KardiaComplete meets people’s need for coaching and care in the moments that matter.

“KardiaComplete goes beyond short-term monitoring and education to offer payers and employers a more robust solution to manage patient care and drive lasting results,” said Priya Abani, Chief Executive Officer, AliveCor. “We have brought our deep heritage in AI and user-friendly devices and services to invent a single virtual disease management program that can augment existing programs and streamline patient care.”

Fueled by AliveCor’s AI-powered connected devices and services, KardiaComplete’s specialized live and digital heart health coaching helps address these conditions by offering lifestyle management tools that promote heart-healthy diet, movement, stress management and healthy sleep. In addition, a nationwide affiliated cardiologist care team co-manages patients with their primary care physicians utilizing evidence-based medication recommendations to help improve clinical outcomes.

KardiaComplete also offers support from a virtual assistant and personalized analyses of heart data to empower people living with heart conditions to better manage their health. Together, these features are designed to improve patient outcomes and reduce spending. In a modeled claims analysis of eligible commercial health plan members with hypertension and/or atrial fibrillation, KardiaComplete saved an estimated $160 per enrollee per month after one year by saving on acute events and disease progression.2

“Reducing the cost of heart care requires not only addressing established disease but also reducing the risk of disease progression that can lead to even greater downstream economic impacts,” said Archana Dubey, MD, Chief Clinical Officer, AliveCor. “By making it easier for people to take positive steps earlier in their journey, KardiaComplete aims to help those with early disease prevent further disease progression, and those with established disease to contain cardiovascular damage that can lead to stroke, congestive heart failure and other serious conditions.”

AliveCor plans to expand its future KardiaComplete offerings to people living with other serious heart conditions, such as heart failure and coronary artery disease.

SourceAliveCor
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy